<DOC>
	<DOCNO>NCT01725646</DOCNO>
	<brief_summary>1 . Evaluation efficacy Omacor® Taiwanese hypertriglyceridemia patient 2 . Evaluation safety Omacor® Taiwanese hypertriglyceridemia patient</brief_summary>
	<brief_title>An Efficacy Safety Study Omacor® Taiwanese Hypertriglyceridemic Patients</brief_title>
	<detailed_description>The primary end point evaluate efficacy safety Omacor Taiwanese hypertriglyceridemia patient .</detailed_description>
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<criteria>Patient fast serum TG ≥ 200 mg/dL 1000 mg/dL Patients history pancreatitis consider risk develop pancreatitis Patient history severe cardiovascular event revascularization procedure within 6 month prior randomization</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Hypertriglyceridemia , omega-3-acid ethyl ester</keyword>
</DOC>